期刊文献+

前列腺素E_1结合舒血宁治疗缺血性脑梗死的疗效观察(附156例报告) 被引量:4

Observation of therapeutic effect of ischemic cerebrum infarction tre ated with prostin E_1 and combined with Shu Xue Ning (Report of attached 156 cases)
下载PDF
导出
摘要 目的探讨前列腺素E1结合舒血宁治疗缺血性脑梗死的临床疗效及安全性。方法156例缺血性脑梗死患者随机分成观察组和对照组,两组基础治疗相同,观察组在此基础上加用前列腺素E110μg,舒血宁注射液20mL,两组在治疗前后均进行神经功能缺损程度评分及血液流变学检查。结果前列腺素El结合舒血宁能减少脑梗死患者神经功能缺损程度评分及血液流变学的变化;治疗缺血性脑梗死有效率为90.52%;对照组有效率为67.13%,两组相比差异有显著性(P<0.05)。结论前列腺素E1结合舒血宁能减少缺血性脑梗死患者神经功能缺损程度评分,治疗缺血性脑梗死有效。 [Objective] To study the clinic effect and safety of Ischemic Cerebr um Infarction treated with Prostin E1 and Combined with Shu Xue Ning. [Methods ] 156 patients with Ischemic Cerebrum Infarction were randomly divided into tes t group and control group. The basic treatments of two groups were identical. Ba sed on the basic treatments, the test group was treated with Prostin E1 10 μg a nd Shu Xue Ning injection 20 mL. The loss level on nerve function were marked an d the changes of blood flowing were examined in two groups before and after trea tment. [Results] The therapy of Ischemic Cerebrum Infarction treated with Pros tin E1 and Combined with Shu Xue Ning could decreased the loss level of nerve fu nction and the changes of blood flowing. The effective therapy rate of Ischemic Cerebrum Infarction was 90.52%. The effective rate of the control group was 67.1 3%. There was significantly statistical difference between two groups(P<0.05). [Conclusions] The therapy of ischemic cerebrum infarction treated with Prostin E1 and combined with Shu Xue Ning can decreased the loss level on nerve functio n and the changes of blood flowing and is effective.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第10期1543-1545,共3页 China Journal of Modern Medicine
关键词 前列腺素E1 舒血宁 缺血性脑梗死 prostin E1 Shu Xue Ning ischemic cerebrum infarction
  • 相关文献

参考文献9

二级参考文献31

  • 1刘同奎,修萍,董玉珠,马立群.急性心肌梗塞溶栓治疗的现状[J].中国危重病急救医学,1996,8(6):374-376. 被引量:4
  • 2中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 3黄元桂.脑血管病的康复医疗方案及评估标准[J].中国康复医学杂志,1990,5(3):135-135.
  • 4[1]Krumholz HM,Chen J,Wang Y,et al.Comparing AMI mortality among hospitals in patients 65 years of age and older:evaluting methods of risk adjustments.Circulation,1999:99(23):2986~2992
  • 5[3]Miller TR,Grossman SJ,Schectman KB,et al.Left ventricular diastolic filling and its association with age.Am J Cardiol,1986;58:531~535
  • 6[4]Borzak S,Cannon CP,Kraft PL,et al.Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina TiMi 7 in Vestigators Thrombin inhibition in Myocardial zschemia.Am J Cardiol,1998 Mar 15;81(6):678~681
  • 7[5]White HD,Barbash GI,Califf RM,et al.Age and outcome with contemporary thrombolytic therapy:results from the GUSTO-T trial.Circulation,1996;94:1826~1833
  • 8[6]Krumholz HM,Murilo JE,Chen J,et al.Thrombolytic therapy for eligile elderly patients with acute myocardial infarction.JAMA,1995;273:1509~15014
  • 9[7]Perez-Castellano N,Garcia E,Serrano JA,et al.Efficacy of invasive strategy for the managemetn of acute myocardial infarction complicated by cardiogenic shock.Am J Cardiol,1999;83(77):989~993
  • 10[8]Lindblomm EJ,Stevermer JJ.Cardiac tropnin I as a marker for AMI (letter).Am Heart J,1999;138(4):798~800

共引文献33046

同被引文献53

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部